-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Edwards Lifesciences Corp quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
- Edwards Lifesciences Corp Operating Income (Loss) for the quarter ending June 30, 2024 was $369M, a 40.1% increase year-over-year.
- Edwards Lifesciences Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was $1.64B, a 9.1% increase year-over-year.
- Edwards Lifesciences Corp annual Operating Income (Loss) for 2023 was $1.53B, a 12.3% decline from 2022.
- Edwards Lifesciences Corp annual Operating Income (Loss) for 2022 was $1.75B, a 3.44% increase from 2021.
- Edwards Lifesciences Corp annual Operating Income (Loss) for 2021 was $1.69B, a 88.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)